Clínico San Carlos Hospital

Information

addictions, Alzheimer's, cancer, diabetes, cardiovascular diseases, neurodegenerative diseases, rare diseases, immunology

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Acute Cardiac Care Unit Coordinator. Cardiovascular Institute. Hospital Clínico San Carlos. Madrid; Associate Professor of Medicine at Complutense University of Madrid; and President of the Association of Ischemic Heart Disease and Acute Cardiac Care of the Spanish Society of Cardiology

Head of the Neurology Section and coordinator of the Multiple Sclerosis Unit at the Hospital Clínico San Carlos.

Head of the Advanced Development Group on Arrhythmia Mechanisms and Therapies at the National Centre for Cardiovascular Research (CNIC), cardiologist at the Health Research Institute of the San Carlos Clinical Hospital and member of CIBERCV

Specialist in Clinical Psychology at the Institute of Psychiatry and Mental Health of the Hospital Clínico San Carlos and member of the Spanish Society of Clinical Psychology ANPIR

Head of Cardiology at San Carlos Clinical Hospital and professor at Complutense University of Madrid

professor of Obstetrics and Gynaecology at the Universidad Complutense de Madrid, president of the Spanish Association for the Study of Menopause (AEEM)

Contents related to this centre
Colchicine

A review conducted by the Cochrane Collaboration analyzed the effects of colchicine—a medication commonly used to treat some rheumatic diseases—on people who had already experienced a cardiovascular event. The review included 12 clinical trials with more than 23,000 patients and concluded that colchicine reduces the risk of stroke or heart attack in these individuals. Overall, for every 1,000 people treated, there were 9 fewer heart attacks and 8 fewer strokes compared to those who did not take the medication, with no apparent serious side effects.

pills and ECG

A meta-analysis concludes that the use of beta-blockers is not necessary in patients who have suffered a heart attack but have normal cardiac function. The research, coordinated in Spain by the CNIC, brings together data from five clinical trials and 17,801 patients. One of these trials, REBOOT, already showed that patients who did not have reduced cardiac function after a heart attack did not benefit from treatment with beta blockers. According to this recent meta-analysis, published in the New England Journal of Medicine and presented at the American Heart Association Congress in New Orleans (USA), the use of these drugs does not reduce mortality, reinfarction or heart failure in this group of patients.

pacemaker

An international team has created a tiny temporary pacemaker, smaller than a grain of rice (1.8 mm × 3.5 mm × 1 mm). The device is resorbable by the body, achieves effective pacing in human and various animal cardiac models, and could be implanted less invasively than existing pacemakers, according to a study published in Nature.

 

woman

A study led by researchers in Canada has analysed the relationship between perimenopausal symptoms and later cognitive and behavioural problems in nearly 900 women. Their findings are that those with more symptoms were more at risk of cognitive problems and dementia later in life. The results are published in the journal Plos One.

wine

In a group of people at high cardiovascular risk, low to moderate wine consumption was associated with fewer cardiovascular events (cardiovascular death, myocardial infarction, stroke or heart failure), according to a study. The analysis uses urinary concentrations of tartaric acid, a substance found in grapes and grape derivatives, as a biomarker of wine consumption. It finds that consuming between three and 35 glasses per month was associated with fewer cardiovascular events than in people who consumed fewer than three or more than 35 glasses. The study, published in the European Heart Journal, included more than 1,200 participants from Spain's PREDIMED study with an average age of 68 years.

woman

Hormonal therapy to treat breast cancer is associated with a lower risk of Alzheimer's disease and dementia in women over 65, a study says. The retrospective analysis is based on data from more than 18,000 women with breast cancer in the US: two-thirds of them had received hormone therapy and one-third had not. The "protective effect" of hormone therapy declines with age and varies by ethnicity, adds the article published in JAMA Network Open

 

airplane

Drinking alcohol and sleeping in hypobaric conditions - such as those of an aircraft cabin - could be a risk to cardiovascular health, a study warns. Researchers compared a group of 23 people sleeping in a laboratory with another group of 17 people sleeping in a high-altitude chamber, replicating conditions at about 2,400 metres above sea level. The combination of alcohol consumption and hypobaric hypoxia during the simulation "reduced sleep quality, challenged the cardiovascular system and led to extended duration of hypoxaemia," the authors state in the journal Thorax.

VPH

A study in South Korea followed more than 160,000 women for more than eight years and concluded that infection with different strains of human papillomavirus is associated with a fourfold increase in the relative risk of dying from cardiovascular causes. According to the authors, "it could be that the virus causes inflammation in the blood vessels, contributing to blockage and damage to the arteries". The findings are published in the European Heart Journal.

chimpancés

The vast majority of mammals remain fertile until the end of their lives. Humans and some species of whales deviate from that norm and do go through menopause. Now, research published in Science reveals that menopause exists in female chimpanzees, too, and that it lasts for a fifth of their adult lifespan. To reach these conclusions, the research team observed 185 female chimpanzees between 1995 and 2016 in Uganda's Kibale National Park and measured hormone levels in urine samples from specimens of various ages.

Online harassment

On the occasion of World Mental Health Day on 10 October, the Science Media Centre Spain organised an information session on the mental health of young people and the threat posed by deepfakes and cyberbullying. At the meeting, experts Esther Calvete and Irene de la Vega explained their risks and possible repercussions, their characteristics and some tools to reduce their frequency and impact.